AVEFF (Avecho Biotechnology) Common Stock: $164.05 Mil (As of Dec. 2025)


What is Avecho Biotechnology Common Stock?

Avecho Biotechnology AVEFF -74.14% Common Stock is $164.05 Mil as of Dec. 2025. The stock has 2 warning signs investors should review.

Avecho Biotechnology's quarterly common stock increased from Dec. 2024 ($154.91 Mil) to Jun. 2025 ($159.27 Mil) and increased from Jun. 2025 ($159.27 Mil) to Dec. 2025 ($164.05 Mil).

Avecho Biotechnology's annual common stock declined from Dec. 2023 ($163.73 Mil) to Dec. 2024 ($154.91 Mil) but then increased from Dec. 2024 ($154.91 Mil) to Dec. 2025 ($164.05 Mil).

Avecho Biotechnology Common Stock Historical Data

* Premium members only.

The historical data trend for Avecho Biotechnology's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avecho Biotechnology Common Stock Chart

Avecho Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 169.96 160.28 163.73 154.91 164.05

Avecho Biotechnology Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 163.73 162.42 154.91 159.27 164.05

Avecho Biotechnology Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $164.05 Mil mean?
Avecho Biotechnology (AVEFF) has a Common Stock of $164.05 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Avecho Biotechnology and its competitors.
Is Avecho Biotechnology's Common Stock too high?
Avecho Biotechnology's current Common Stock is $164.05 Mil.
How does Avecho Biotechnology's Common Stock compare to VRTX and REGN?
Avecho Biotechnology's Common Stock of $164.05 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Avecho Biotechnology and its competitors. Avecho Biotechnology's current Common Stock is $164.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avecho Biotechnology stock overvalued right now?
Avecho Biotechnology (AVEFF) has a current Common Stock of $164.05 Mil. The current Common Stock is $164.05 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Avecho Biotechnology (AVEFF), the current Common Stock is $164.05 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avecho Biotechnology Business Description

Other Exchanges OEZ:GermanyAVE:Australia
Address Unit A8, 2A Westall Road, Clayton, Melbourne, VIC, AUS, 3168
Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sales, and licensing of products incorporating its patented platform technology Tocopheryl Phosphate Mixture (TPM), for the pharmaceutical, skincare, and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches, including the conduct of research and development activities. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.